Categories
Change Password!
Reset Password!
Short-term nimesulide use demonstrates good tolera...
Taking NSAIDs after 60? Study warns of increased G...
A large hospital-based study from Beijing has identified significant risk factors associated with nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointe...
Long-term intramuscular cyanocobalamin therapy in...
Corpus atrophic gastritis (CAG) is a chronic autoimmune condition characterized by progressive loss of gastric acid secretion and intrinsic factor production, r...
First-line antiviral for chronic hepatitis B: Teno...
Chronic hepatitis B (CHB) poses a substantial global health burden requiring effective long-term antiviral therapy.
Tegoprazan emerges as fast-acting alternative to P...
A large study has positioned tegoprazan, a potassium-competitive acid blocker (PCAB), as a next-generation therapy for gastroesophageal reflux disease (GERD)&md...
Low-dose aspirin raises gastric and duodenal ulcer...
A large population-based analysis of over 220,000 volunteers has revealed that low-dose aspirin initiation is connected with increased risk of gastric ulcer and...
Diagnosis and Management of GERD: Updates from Lyo...
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal ailments globally, impacting approximately 1.03 billion individuals.
Patient interviews reveal gaps in primary care sup...
Primary biliary cholangitis (PBC) is a rare yet relentlessly progressive autoimmune liver disease that necessitates lifelong surveillance and close coordination...
Global PPI use hits 25%: Study flags rising long-t...
A large-scale systematic review assessing global trends in proton pump inhibitor (PPI) use has revealed that these acid-suppressing drugs are used by nearly 25%...
High-dose vs. conventional therapy for H. pylori e...
Optimizing Helicobacter pylori (H. pylori) eradication therapy is fundamental in the era of rising antibiotic resistance.
